Abstract: Disclosed are novel compounds of Chemical Formula 1, optical isomers of the compounds, and pharmaceutically acceptable salts of the compounds or the optical isomers. The compounds, isomers, and salts exhibit excellent activity as GLP-1 receptor agonists. In particular, they, as GLP-1 receptor agonists, exhibit excellent glucose tolerance, thus having a great potential to be used as therapeutic agents for metabolic diseases. Moreover, they exhibit excellent pharmacological safety for cardiovascular systems.

Abstract: A color discharge display panel is disclosed in which cathodes and anodes are arranged on the upper face of a rear plate, stripe shaped insulating layers forming a matrix form together with the anodes are disposed at the bottoms of the cathodes, and separating ribs and barriers having a lower height are respectively disposed at the opposite edges of the insulation layers. Due to the barriers disposed between the cathodes and anodes, the discharge channels are formed in a round-about form, and consequently, the length of the discharge channel per volume of the discharge space is maximized, with the result that the thickness of the panel becomes thinner compared with that of the conventional panes, and that the realization of a high luminance picture is made possible due to the high discharge efficiency.